+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 100Years
FEMALE
ID05574673

Observational Study of Epithelial Ovarian Cancer Patients by BRCA and Homologous Recombination Status Including Long- and Short-Term Treatment Response Characterization

Led by Nordic Society of Gynaecological Oncology - Clinical Trials Unit · Updated on 2026-02-27

1000

Participants Needed

1

Research Sites

217 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying a large group of newly diagnosed epithelial ovarian cancer patients from multiple countries to understand how ovarian cancer is distributed based on certain genetic features, specifically mutations in BRCA12 genes and homologous recombination deficiency HRD status. The study aims to identify clinical and molecular markers that distinguish patients with different treatment responses, focusing on both short- and long-term responders. It also seeks to collect clinical samples for further analysis of markers that could predict treatment outcomes. Participants receive standard care treatments as guided by local and national protocols, with no experimental treatments assigned by the study. The study is divided into two observational periods the first tracks patients from diagnosis through their initial chemotherapy response, progression, or death the second follows patients for up to 60 months after their first treatment response to study longer-term outcomes and differences between short- and long-term responders. During the study, participants will provide clinical information and tumor tissue samples. Researchers will monitor patient outcomes, including disease progression and survival, using standard medical assessments and tests over the study duration. The study will collect data for up to 60 months after initial chemotherapy response, aiming to improve understanding of ovarian cancer behavior and treatment response in real-world settings.

CONDITIONS

Brief Title

Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype

Research Team

K

Kristine Madsen, MD

H

Henriette W Hansen, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here